Market Tracker

04/29 5:16pm ET

ImmunoGen Inc (NASDAQ:IMGN)

6.85
Delayed Data
As of Apr 29
 -1.60 / -18.93%
Today’s Change
6.59
Today|||52-Week Range
19.43
-49.52%
Year-to-Date

Today’s Trading

Previous close8.45
Today’s open7.07
Day’s range6.59 - 7.25
Volume5,302,751
Average volume (3 months)1,030,095
Market cap$596.4M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-106.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book16.89

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.42-2.18%
NKNantKwest Inc-0.30-3.49%
RLYPRelypsa Inc-0.40-2.16%
ADAPAdaptimmune Therapeu...+0.24+2.54%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts